I have worked with patients diagnosed with ALS and stroke throughout my career. The patient tends to deteriorate fast, and doctors that I have talked to have spoken highly of stem cell research and how it can help these patients. I believe CUR is just getting started and I highly believe that with good results, CUR can reach levels that SRPT has reached in 2012. My target remains $2 by the end of 2012, to $8-10 by end of 2013.
"My target remains $2 by the end of 2012, to $8-10 by end of 2013."
Well $2 by the end of 2012 didn't quite happen, but I wouldn't mind seeing the $8-10 by the end of this year. Probably a more realistic, though still highly ambitious target for 2013 is $4-5. In any case, looks like there's still a ton of potential upside here.